Bridgeway Capital Management’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
Other funds holding XBIT
Bridgeway Capital Management's XBIT Position: Q3 2026 in Review
Bridgeway Capital Management held its XBiotech (XBIT) position steady in Q3 2026 at 98,447 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.
Bridgeway Capital Management first reported a position in XBIT in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.21M in Q1 2024. 31 funds tracked by Wall St. Rank hold XBIT as of Q3 2026.
- Bridgeway Capital Management held 98,447 shares of XBiotech worth $216K as of Q3 2026.
- Bridgeway Capital Management left its XBiotech share count unchanged in Q3 2026.
- XBiotech made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #1000 holding.
- Bridgeway Capital Management first reported a position in XBiotech in Q2 2020 and has held it in 19 quarters since.
- Bridgeway Capital Management's XBiotech position peaked at $1.21M in Q1 2024.
- 31 funds tracked by Wall St. Rank held XBiotech as of Q3 2026.
Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.